Effect of concomitant icosapent ethyl (eicosapentaenoic acid ethyl ester) on the pharmacokinetics of atorvastatin

Clinical drug investigation

Volumn 35, Issue 1, 2015, Pages 45-51

  Braeckman, Rene A ^a   Stirtan, William G ^a   Soni, Paresh N ^a  

^a Amarin Pharma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; PYRROLE DERIVATIVE;

ADULT; ANALOGS AND DERIVATIVES; COMBINATION DRUG THERAPY; CROSSOVER PROCEDURE; DRUG INTERACTION; FEMALE; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ATORVASTATIN CALCIUM; CROSS-OVER STUDIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES; TREATMENT OUTCOME;

EID: 85003230050     PISSN: None     EISSN: 11791918     Source Type: Journal    
DOI: 10.1007/s40261-014-0252-8     Document Type: Article

References (0)